InvestorBrandNetwork (IBN) Content Platform

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), an innovative technology and lithium project development company, is participating in PI Financial’s The Future is Lithium Conference. Slated for Nov. 8, 2022, the virtual event presents a “crash course” in the lithium developer space. SLI is one of six Americas-focused lithium developers and explorers chosen to present during the one-day event. Standard Lithium CEO Robert Mintak will be presenting an overview of the company during the gathering; his presentation will begin at 8:50 a.m. PT. “With many spot lithium carbonate and hydroxide prices printing record highs in recent weeks, and a yawning gap between supply and demand emerging under even the most optimistic assumptions, we see the lithium space offering significant upside potential for projects that have scale, developability, and access to capital,” the conference announcements states. “While sky-high sale prices represent a significant upside opportunity if they persist, we see many development projects offering attractive returns even at lithium prices a fraction of those seen in spot markets.”

To attend the event, visit https://ibn.fm/afv7F   

To view the full press release, visit https://ibn.fm/UszAX

About Standard Lithium Ltd.

Standard Lithium is an innovative technology and lithium development company with a portfolio of projects under development. The company’s flagship projects, the LANXESS Project and the South-West Arkansas Project, are located in southern Arkansas near the Louisiana state border. The company is focused on the evaluation and testing of commercial lithium extraction and purification from brine sourced from approximately 180,000 acres of unitized leases across these two projects. SLI operates a first-of-a-kind, industrial-scale direct lithium extraction (“DLE”) demonstration plant at the LANXESS Project. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. A definitive feasibility study (“DFS”) and front-end engineering study (“FEED”) for phase 1A of the LANXESS Project commenced in September 2022. A preliminary feasibility study (“PFS”) of the South-West Arkansas Project commenced in May 2022. The company is also pursuing the resource development of approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. For more information about the company, please visit www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

The Intelligent Cities Summit, Canada’s largest event geared towards public sector professionals, has announced that this year’s event will feature four simultaneous summits; the event will also be offered in a hybrid format, with in-person activities taking place in Toronto. The event is scheduled for Nov. 9–10, 2022. A one-of-a-kind showcase event, the summit is organized by IOT Events and designed to advance the deployment of cutting-edge technology to improve citizen services. According to the announcement, the two-day summit provides an ideal learning and networking environment for delegates and practicing professionals from Canada, the United States and beyond to share insights, explore policy strategies, leverage state-of-the-art learning avenues, and explore the newest city-governance tools and best practices. This year’s event offers four public-sector summits: Intelligent Cities Summit, IoT Code Orange Summit, IoT People First Summit and IoT Health Care. Each summit offers an agenda featuring engaging expert speakers addressing an array of relevant and valuable topics, along with insightful panel discussions, seminars and virtual panels.

To join the summit, visit https://ibn.fm/T3ITM

To view the full press release, visit https://ibn.fm/9nyeL

About the Intelligent Cities Summit

The Intelligent Cities Summit serves as a forum where global public sector leaders converge to ponder all aspects of creating an Intelligent and efficient public sector of tomorrow. Through focused panel discussions, presentations and case studies, the speaking faculty at the summit, which includes global municipal leaders and tech experts, offers new perspectives on all aspects of the public sector. Through its summits, productive workshops, exhibitions and immense networking opportunities, the event offers a comprehensive view of the various facets that combine to build and sustain a better future for our citizens and the catalytic role of technology in this process. For more information about this event, visit www.IntelligentCities.ca.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Propanc Biopharma (OTC: PPCB) is developing a novel approach to prevent recurrence and metastasis of solid tumors by using pancreatic proenzymes that target and eradicate cancer stem cells in patients suffering from pancreatic, ovarian and colorectal cancers. The company’s novel proenzyme therapy is based on the science that enzymes stimulate biological reactions in the body, especially enzymes secreted by the pancreas. These pancreatic enzymes could represent the body’s primary defense against cancer. For more information, visit the company’s website at www.Propanc.com.

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, provides the online investment community with custom-built portals that include summaries on hundreds of presenting companies. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of various investor conferences.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Acasti Pharma (NASDAQ: ACST) (TSX.V: ACST) is a specialty pharma company advancing three clinical stage drug candidates addressing rare and orphan diseases. Acasti’s novel drug candidates have the potential to improve the performance of currently marketed drugs by achieving faster onset of action, enhanced efficacy, reduced side effects, and more convenient drug delivery—all which could help to increase treatment compliance and improve patient outcomes. Acasti’s three lead clinical assets have each been granted Orphan Drug Designation by the FDA, which provides the assets with seven years of marketing exclusivity post-launch in the United States, and have additional intellectual property protection with over 40 granted and pending patents. Acasti’s lead clinical assets target underserved orphan diseases: (i) GTX-104, an intravenous infusion targeting Subarachnoid Hemorrhage (“SAH”), a rare and life-threatening medical emergency in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull; (ii) GTX-102, an oral mucosal spray targeting Ataxia-telangiectasia (A-T), a progressive, neurodegenerative genetic disease that primarily affects children, causing severe disability, and for which no treatment currently exists; and (iii) GTX-101, a topical spray targeting Postherpetic Neuralgia (“PHN”), a persistent and often debilitating neuropathic pain caused by nerve damage from the varicella zoster virus (shingles), which may persist for months and even years. For more information, visit the company’s website at www.AcastiPharma.com/en.

To view IBN’s virtual coverage of Investor Summit Group’s Q4 Event, visit  https://ibn.fm/InvestorSummit2022Q4Portal

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, is providing the online investment community with a custom-built portal that includes summaries on each of the companies participating at this quarter’s Investor Summit. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN is using social media and syndicated articles to maximize the visibility of the event.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. The company today announced that it will host a conference call and webcast at 2:00 p.m. Pacific Time on Nov. 10, 2022, to report financial results for its fiscal year 2023 second quarter ended Sept. 30, 2022. Interested parties should visit https://ibn.fm/oJeMj to access the webcast and dial 1-888-599-8686 (toll-free U.S.) or 1-929-477-0402 (toll/international) and enter conference ID: 5975082 to join the call. Participants are asked to access the webcast site ten minutes before the start of the call. In addition, a telephone replay will be available after approximately 5:00 p.m. Pacific Time on Nov. 10 as detailed in the news release.

To view the full press release, visit https://ibn.fm/nPGpZ

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage, CNS-focused biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting and with fewer side effects and safety concerns than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. Candidates include PH94B and PH10, which belong to a new class of drugs known as pherines, which are investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression – one mind at a time. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Bion Environmental Technologies (OTCQB: BNET), a developer of advanced livestock waste treatment technology that dramatically reduces environmental impacts and recovers valuable resources, has broken ground on a small commercial-scale Gen3Tech facility that will be located near Fair Oaks, Indiana. According to the announcement, Bion expects building construction to be completed by Dec. 15, 2022, with waste processing equipment delivered by mid-January. The Gen3Tech platform’s successful operation at Fair Oaks will demonstrate its scalability and allow nitrogen recovery efficiencies to be optimized at scale. Bion will use operating data from the Fair Oaks facility to design its first full-scale commercial project and support certification requirements for various regulatory agencies to establish a USDA-certified sustainable brand. In addition, the facility will produce ammonium bicarbonate fertilizer for both commercial testing by potential joint venture partners and university growth trials.

“A couple key takeaways: first, this is the final engineering step before we are ready to launch full-scale commercial projects. While we expect normal engineering challenges associated with scaling up, we don’t anticipate any major ones because most of this equipment is already in use at larger scale,” said Craig Scott, Bion’s director of communications. “Second, and most important: we are NOT another digester company that will power a couple thousand homes from cow manure. Bion’s key differentiator is the comprehensive solution we bring to all the environmental problems associated with livestock waste – air, water and soil – not just methane and climate change. That comprehensive solution also generates multiple revenue streams, not just one. And while climate impacts need to be addressed, we believe the more pressing problem is the industry’s direct impacts to water quality and human health. In our opinion, developing anaerobic digester projects to extract renewable energy, without addressing ammonia/ nutrient control, is a ticking timebomb that will create greater problems in the future.”

To view the full press release, visit https://ibn.fm/NfvYm

About Bion Environmental Technologies Inc.

Bion’s patented third generation technology (“Gen3Tech”) was designed to largely mitigate the environmental impacts of large-scale livestock production and deliver a USDA-certified sustainable product to the consumer. The platform simultaneously recovers high-value environmentally friendly fertilizer coproducts and renewable energy that increase revenues. Bion’s Gen3Tech platform can create a pathway to economic and environmental sustainability with “win-win” benefits for a premium sector of the $175 billion U.S. livestock industry and the consumer. For more information, see Bion’s website at www.BionEnviro.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in the United States and China focused on early cancer screening and detection, is able to continue to list its shares on the NASDAQ Capital Market. The company received the notification from Nasdaq Hearings Panel of the Listing Qualifications Department of the Nasdaq Stock Market LLC. The status is subject to ANPC demonstrating compliance with the $1 Bid Price listing rule by Nov. 23, 2022, as well as all other requirements for continued listing. AnPac has been working with the market since being notified earlier this year that the bid price of its listed security had closed at under $1 per share for the previous 30 consecutive business days, meaning the company did not comply with the $1 Bid Rule. The company was given time to comply with the rule; AnPac ultimately requested a hearing before the NASDAQ Hearings Panel to present its financial data and plan, including a share reverse split, to regain compliance with the $1 Bid Rule. The most recent decision was made after that hearing, which was held on Oct. 202, 2022. Based on that decision, AnPac will continue to be listed and its shares will continue to be traded on NASDAQ, pending a final written decision by the exchange’s hearings panel after Nov. 23, 2022.

To view the full press release, visit https://ibn.fm/LhGQa

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of March 31, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. According to a report by Frost & Sullivan, AnPac Bio ranked first globally in multicancer screening and detection-test sample volume, accumulative to January 2021. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of more than 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nemaura (NASDAQ: NMRD) is a medical technology company focused on developing and commercializing noninvasive wearable diagnostic devices and supporting personalized lifestyle coaching programs. RedChip Companies has announced that it will air a new interview with Nemaura on the RedChip Money Report(R) on Bloomberg TV at 7 p.m. Eastern Time on Nov. 5, 2022. Bloomberg TV is available throughout an estimated 73 million homes across the U.S. In the exclusive interview, Nemaura’s CEO Dr. Faz Chowdhury discusses the company’s continuous glucose sensor, the sugarBEAT(R), its potential impact on the 500 million people around the world affected by diabetes, Nemaura’s technology optimization plan, and much more. Interested parties should visit https://ibn.fm/oLZas to access the interview in its entirety.

To view the full press release, visit https://ibn.fm/uEseF

About Nemaura Medical Inc.

Nemaura is a medical technology company developing and commercializing noninvasive wearable diagnostic devices. The company is currently commercializing sugarBEAT(R) and proBEAT(TM). sugarBEAT, a CE mark approved Class IIb medical device, is a noninvasive and flexible continuous glucose monitor (“CGM”) providing actionable insights derived from real time glucose measurements and daily glucose trend data, which may help people with diabetes and prediabetes to better manage, reverse and prevent the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Application) for sugarBEAT to the U.S. FDA. proBEAT combines noninvasive glucose data processed using artificial intelligence and a digital health care subscription service that has been launched in the U.S. as a general wellness product as part of its BEAT(R) diabetes program that is currently undergoing pilot studies. The company sits at the intersection of the global type 2 diabetes market that is expected to reach nearly $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight loss and wellness applications that is estimated to reach $60 billion by 2023. For more information, visit the company’s website at www.NemauraMedical.com.

NOTE TO INVESTORS: The latest news and updates relating to NMRD are available in the company’s newsroom at https://ibn.fm/NMRD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

SurgePays Inc. (NASDAQ: SURG), a technology and telecommunications company focused on the underbanked and underserved, has started the process to apply to dual list its shares of common stock on Upstream, the revolutionary trading app for digital securities and NFTs; the app is powered by Horizon Fintex and MERJ Exchange Limited. According to the announcement, the company anticipates the Upstream dual listing will provide access to a global, digital-first investor base that can trade using USDC digital currency as well as credit, debit, PayPal and USD. This wider reach could unlock liquidity and enhance price discovery while also offering international investors the opportunity to invest in a NASDAQ-listed company. The announcement noted that Upstream is a fully regulated global stock exchange that allows users to trade NFTs and invest in securities for IPOs, crowdfunded companies, and U.S. and international equities, as well as celebrity ventures. “We believe a dual listing on Upstream provides our company access to the global capital markets and the technology to reach countless potential new investors,” said SurgePays CEO and chair Brian Cox in the press release. “In addition, as an advocate of the underbanked and underserved, the Upstream platform opens up the world of digital assets to those without bank accounts, brokerage accounts or credit cards. We have an exciting story to tell and believe this listing provides an even greater audience to learn about our growth potential. I expect the relationship with Upstream to develop beyond the dual listing. We are planning to integrate a Web3 community-building strategy using Upstream’s carbon neutral, noncustodial Web3 platform to distribute digital coupons (incentive NFTs) for prepaid wireless and mobile broadband subscribers to redeem for discounts and other rewards at stores transacting on the SurgePays platform.”

To read the full press release, visit https://ibn.fm/pIjn7

About SurgePays Inc.

SurgePays is a technology and telecommunications company focused on the underbanked and underserved communities. SurgePhone Wireless provides mobile broadband to low-income consumers nationwide. SurgePays blockchain fintech platform utilizes a suite of financial and prepaid products to convert corner stores and bodegas into tech hubs for underbanked neighborhoods. For more information about the company, visit www.SurgePays.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23-certified backcountry aircraft, has built aircraft that has been flown around the world for many reasons. Brent Dodd and his CubCrafters Carbon Cub EX are flying for what may be the most important reason of all — to save lives. Serving in Mexico for the United Indian Mission, Dodd is the organization’s director of flight operations; he also serves as an airframe and power-plant mechanic and is the pilot of the Carbon Cub, which has been slightly modified for its life-saving work. According to Dodd, who was featured in a recent article AOPA article, the Carbon Cub’s 29-inch tires and AOSS suspension are a “huge plus” as he lands and takes off on a 600-foot-long, dirt airstrip in Mexico. The article notes that, during the past three years alone, Dodd has flown 477 people and 13,069 pounds of cargo to and from the rural villages and hospitals. “A ten-minute flight saves on average a three-hour drive on rough roads,” said missionary pilot Brent Dodd in the article. “And most people don’t have cars. . . . Because of the remoteness of the area that I fly in, if the hospital did not provide [air transport, these people] would have died.”

To read the full article, visit https://ibn.fm/hn1nN

About Cub Crafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80-plus-year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA and Part 23-certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to Cub Crafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CORRECTION: This content was previously syndicated with an error, stating “With access to over 320 profiles in the U.S. alone. . . ” The corrected version below states: “With access to over 320 million profiles in the U.S. alone. . . ”

Reklaim (TSX.V: MYID) (OTCQB: MYIDF) is the destination for consumers to access and reclaim their data. The company appears poised to position itself as the go-to solution for businesses under swelling pressure to find a partner to solve the compliance gap that has arisen from the transformation of consumer privacy regulations as well as how Big Tech has adapted to changing consumer sentiment and legislation. “With the days of cookies and retargeting ads gone, brands are forced to rethink their marketing strategy – and access to consumer-consented data purchased from a compliant supplier with scale is deemed the critical step toward advertising in the modern, privacy first world. With access to over 320 million profiles in the U.S. alone, Reklaim emerges as a partner that can respond to these privacy challenges,” reads a recent article. “Its unique data platform serves consumers and brands alike. Reklaim prides itself on being the world’s only company providing consumers with access to digital information collected about them and guaranteed weekly monetization. They can view, edit, opt out, or be compensated when businesses use their data. At the same time, the platform allows brands and companies to buy and sell consumer-consented, privacy compliant data.”

To view the full article, visit https://ibn.fm/v9w5Q

About Reklaim Ltd.

Reklaim is driven by consumer data and the evolution of privacy. Offering compliant, zero-party data to Fortune 500 brands, platforms and data companies, Reklaim allows consumers to visit the platform, confirm their identity, and unveil data that has been collected and sold for years without the consumer’s explicit consent. Reklaim enables consumers to take back control by setting up a Reklaim account through which, should they choose to, they can be compensated for their data or choose to protect it via a suite of privacy tools. To view more information about the company, visit https://investors.reklaimyours.com.

NOTE TO INVESTORS: The latest news and updates relating to MYIDF are available in the company’s newsroom at https://ibn.fm/MYIDF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of self-contained, automated, indoor “micro-farms” called GrowPods, offer numerous benefits for farmers looking to be dynamic and fluid. GrowPods are unique controlled environment farms that don’t use expensive, dangerous pesticides and herbicides and provide a way for farmers to identify crops that are in short supply and then grow those crops, quickly and efficiently. A recent CNBC report noted that there is currently a “massive strain on global food supply,” especially as the world recovers from the global pandemic. That need, combined with the increasing costs of fertilizer and pesticides, make GrowPods an increasingly attractive option for farmers looking to make changes that will keep their farms viable and profitable. According to the announcement, GrowPods can grow an estimated acre of food in a transportable, scalable, automated system; crops can be grown year round, virtually anywhere, without the labor, expense and risks associated with pivots in traditional farming. “Not only do GrowPods provide highly nutritious food without the use of expensive and dangerous chemicals, but they also offer growers consistent food production year-round, reduced resource consumption, and faster harvest times,” said Advanced Container Technologies CEO Doug Heldoorn in the press release.

To view the full press release, visit https://ibn.fm/GPaRp

About Advanced Container Technologies Inc.

Advanced Container Technologies is in the business of selling and distributing self-contained, automated, indoor “micro-farms” called GrowPods, along with related equipment and supplies. Additionally, the company designs and sells patented proprietary medical-grade plastic containers, known as the Medtainer(R), that store and grind pharmaceuticals, herbs, teas and other solids or liquids. For more information, visit the company’s website at www.AdvancedContainerTechnologies.com.

NOTE TO INVESTORS: The latest news and updates relating to ACTX are available in the company’s newsroom at https://ibn.fm/ACTX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and the Clean Beverage(R) company, today announced its receipt of purchase orders from Big Lots for its Alkaline88(R) 1-liter 12 pack and 16-ounce aluminum bottles. An Ohio-based home discount retailer, Big Lots operates in 47 states with approximately 22 million active members in its customer loyalty program. The Alkaline Water Company will ship initial Alkaline88 orders at the end of November and expects the products to hit shelves before the end of the year. “We’re pleased to offer two great products to Big Lots shoppers in approximately 1,400 stores throughout the country,” said WTER CEO and President Frank Lazaran. “Our 1-liter 12 pack offers deliciously smooth on-the-go sized bottles by the dozen while our eco-friendly aluminum bottle is infinitely recyclable and provides a crisp, cool option for enjoying Alklaline88.”

To view the full press release, visit https://ibn.fm/s6RW1

About The Alkaline Water Company

The Alkaline Water Company is the Clean Beverage(R) company making a difference in the water you drink and the world we share. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for Alkaline88. To purchase The Alkaline Water Company’s products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sigma Additive Solutions (NASDAQ: SASI), a leading developer of quality assurance software to the commercial 3D printing industry, today announced that it is releasing a beta version of the PrintRite3D(R) Machine Health module. According to the update, the new solution marks the beginning of the company’s software-only approach to quality assurance by allowing users to take disparate machine log files and standardize them. “This is an exciting announcement, not only for Sigma, but for the entire additive industry,” said Sigma’s CEO and President Jacob Brunsberg. “Today, proprietary quality control approaches of various additive machine manufacturers often lead to inconsistency in quality assurance across manufacturing operations. The objective of the initial module, and all future modules, is to help drive a standards-based approach to additive manufacturing, allowing users to gain consistency across their sites and supply chains. Allowing users to take disparate machine log files and standardize them is an important first step in connecting distinct sensors and images into a cohesive product suite.”

To view the full press release, visit https://ibn.fm/k7fd2

About Sigma Additive Solutions Inc.

Sigma Additive Solutions is a leading provider of in-process quality assurance (“IPQA(TM)”) solutions to the additive manufacturing industry. Sigma specializes in the development and commercialization of real-time monitoring and analytics known as PrintRite3D(R) for 3D metal and polymer advanced manufacturing technologies. PrintRite3D detects and classifies defects and anomalies real-time during the manufacturing process, enabling significant cost-savings and production efficiencies by reducing waste, increasing yield and shortening cycle times. Sigma believes its software solutions will be a major catalyst for the acceleration and adoption of industrial 3D printing. For more information, please visit www.SigmaAdditive.com.

NOTE TO INVESTORS: The latest news and updates relating to SASI are available in the company’s newsroom at http://ibn.fm/SASI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has announced that its Chief Executive Officer Shawn Singh will present and host one-on-one meetings at the Stifel 2022 Healthcare Conference taking place in New York on Nov. 15 and 16, 2022. Singh’s presentation is scheduled to begin at 9:10 a.m. Eastern Time on Nov. 15. Investors interested in arranging a one-on-one meeting during the event should contact the Stifel 2022 Healthcare Conference coordinator.

To view the full press release, visit https://ibn.fm/4CQFN

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage, CNS-focused biopharmaceutical company striving to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple forms of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression – one mind at a time. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Splash Beverage (NYSE American: SBEV), a portfolio company of leading beverage brands, will be presenting at the Sidoti Microcap Conference held next week. The conference is scheduled for Nov. 9, 2022. During the event, SBEV CEO Robert Nistico will be presenting virtually; Nistico’s presentation is slated to begin at 9:15 am ET. In addition, Splash management will host virtual one-on-ones with investors throughout the conference. SBEV has established a reputation for being an innovator in the beverage sector; the company owns an impressive portfolio of both alcoholic and nonalcoholic beverage brands, including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drinks.

To view the presentation, visit https://ibn.fm/I3eTC

To view the full press release, visit https://ibn.fm/lyrII

About Splash Beverage Group Inc.

Splash Beverage Group, an innovator in the beverage industry, owns a growing portfolio of alcoholic and nonalcoholic beverage brands including Copa di Vino wine by the glass, SALT flavored tequilas, Pulpoloco sangria, and TapouT performance hydration and recovery drinks. Splash’s strategy is to rapidly develop early-stage brands already in its portfolio as well as acquire and then accelerate brands that have high visibility or are innovators in their categories. Led by a management team that has built and managed some of the top brands in the beverage industry and has led sales from product launch into the billions, Splash is rapidly expanding its brand portfolio and global distribution. For more information about the company, please visit www.SplashBeverageGroup.com. 

NOTE TO INVESTORS: The latest news and updates relating to SBEV are available in the company’s newsroom at https://ibn.fm/SBEV

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• Accurate, powerful vision, mission and value statements can distinguish companies from their competition
• The inability to agree upon, articulate these key elements can cause serious problems for a company
• Adherence to guiding principles and values serves all in arriving at the most effective and collaborative decisions, notes SHRG

Aligning a company’s vision, mission and values with its culture seems like an obvious thing, but it’s not unusual to have a disconnect between the two, reports a recent Direct Selling News (DSN) article (https://ibn.fm/GQkuj). Yet companies with powerful, accurate vision, mission and value statements, such as Sharing Services Global (OTCQB: SHRG), often distinguish themselves from others operating in the same space.

“Who are you? It sounds like a silly question. Or the beginning of an awkward introduction,” writes Paul Adams, author of the DSN article. “When I ask the question to a group of executives, I’m asking about who they are as a company. What do you stand for? How do you act? What expectations do you have…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

MetAlert (OTC: MLRT), a pioneer in the field of wearable GPS human and asset tracking and remote patient monitoring, has selected Pod Group’s ENO ONE IoT SIM cards and advanced connectivity solutions for enterprise IoT applications for its award-winning, two-way GPS SmartSole. A wearable medical monitoring device, SmartSole is integrated into an orthotic insole allowing discreet and unobtrusive tracking and remote monitoring of Alzheimer’s, dementia and autism sufferers. “The POD Group partnership is a critical component for the launch of our SmartSole plus, a mobile hot spot connected to other wearable devices,” said MetAlert CEO Patrick Bertagna. “This level of 4G and MB IoT connectivity technology will become very valuable to MetAlert due to the amount of biometric and location data, which will need to be transmitted quickly, securely and inexpensively across the globe.”

To view the full press release, visit https://ibn.fm/p2kJE

About MetAlert Inc.

MetAlert, a pioneer in smart, mobile and wearable tracking and recovery location-based solutions, is supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution of hardware, software and connectivity and develops two-way GPS tracking technologies, which seamlessly integrate with consumer products and enterprise applications. Utilizing the latest in miniaturized, low-power consumption GPS, cellular, RF, NFC and BLE technology, MetAlert products enable subscribers to track in real time the whereabouts of people or high-value assets. The company is known for its game-changing and award-winning patented GPS SmartSole(R) — think Dr. Scholl’s meets LoJack, the world’s first invisible, wearable, technology-tracking device created for those at risk of wandering due to Alzheimer’s, dementia, autism or traumatic brain injury. MetAlert’s business model is built around technology innovation and holds dozens of patents, with many issued patents in the area of GPS tracking. The company has international distributors servicing customers across the globe with subscribers in more than 40 countries and is a U.S. military government contractor. Other customers include public health authorities and municipalities, emergency and law enforcement, private schools, assisted living facilities, NGOs, small business enterprises, senior care homes and consumers. For more information about the company, visit www.MetAlert.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Vision Hydrogen (OTCQB: VIHD), a renewable energy company developing carbon-reduced hydrogen solutions for the commercial, industrial and transportation sectors, is working with a full-service quality, health, safety and environment (“QHSE”) partner on its Green Energy Hub development project in the North Sea Port of Vlissingen, the Netherlands. VisionH2 announced the partnership with BMD Advies South-Netherlands (“BMD”); VIHD’s wholly owned subsidiary Evolution Terminals engaged BMD to offer advice and help coordinate and prepare permit applications as well as support management with local and regional engagement across all stakeholders. BMD will provide services as work progresses on the development project, which will provide import, storage and handling facilities for green- and reduced-carbon energy products and fuels. According to the announcement, 10 consultants from BMD are working to prepare required documents to obtain the remaining permits and EIA. Plans for the facility are on schedule, with remaining construction and environmental permits scheduled to be filed by the end of 2022. BMD has some 100 associates located across nine regional offices throughout the Netherlands and provides services to entrepreneurs, projects and operating businesses with specialist knowledge encompassing occupational health and safety, environment, management and systems, and energy and energy transition. The company has been in operation for more than three decades and has invaluable relationships already established within the ports and other industrial areas.

To view the full press release, visit https://ibn.fm/ODBEQ

About Vision Hydrogen Corporation

VisionH2 is a renewable energy company developing carbon reduced hydrogen solutions for the commercial, industrial and transportation sectors. VisionH2 is leveraging its proven track-record in site procurement and permitting, accelerating pre-development and grid integration to produce low-carbon and green hydrogen. By establishing and negotiating long-life commitments the Company ensures reliable offtake relationships with industry participants seeking to utilize hydrogen as fuel, feedstock, and as a grid balancing & capacitance solution. VisionH2 is committed to providing the lowest carbon solution with the highest yield hydrogen production, storage and distribution services for the European renewable economy and supply chain. For more information about the company, please visit www.VisionH2.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Industrial Nanotech (OTC: INTK), a global nanoscience solutions and research leader, today provided a company update. Among the highlights, the press release included a list of investor communications strategies the company is implementing as well as a brief status update on all announced deals and initiatives over the last 12 months. “Industrial Nanotech Inc. will no longer be outsourcing communications with our current and potential shareholders. The fact is that shareholders and I want the same two things: 1) the company to continue becoming more and more successful; 2) the stock price to accurately reflect those successes in increased shareholder value,” said Industrial Nanotech CEO/CTO Stuart Burchill. “Both the shareholders and I own stock. The shareholders paid for it. I earned it by working for the past 20 years without a salary, only stock compensation. No individual or entity is more motivated for the company to be successful and the shareholder value to increase than the shareholders and me.”

To view the full press release, visit https://ibn.fm/GS4uv

About Industrial Nanotech Inc.

Industrial Nanotech is a global nanoscience solutions and product development leader. For more information, visit www.Industrial-Nanotech.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Medical experts from all over the globe are invited to attend the 3rd Human Factors Engineering & Usability Studies Congress, a live-streaming event that will help medical device professionals adapt to regulatory challenges, logistics, and scheduling issues in a remote work environment.

The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing b2b events. The global event company caters to the informational and networking needs of the…

Read More>>

To learn more, please visit https://ibn.fm/uxij8.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

India Globalization Capital (NYSE American: IGC) is reporting financial results for second quarter 2023, the period ending Sept. 30, 2022. Highlights of the report include the potential shown by IGC-AD1 and TGR-63, the company’s main investigational drug assets, to suppress or ameliorate a key protein in Alzheimer’s cell lines that are responsible for Aβ plaques, a key indicator of Alzheimer’s disease. The company noted that IGC-AD1 is entering phase 2 trials designed to study the treatment of agitation in dementia resulting Alzheimer’s disease and, in preclinical trials, TGR-63 showed potential to reduce neurotoxicity in Alzheimer’s cell lines. The report stated that IGC completed its phase 1 trial for IGC-AD1 and has already submitted a phase 2 protocol to the U.S. Food and Drug Administration (“FDA”) and Health Canada; the new trial will involve 146 patients with Alzheimer’s with half receiving a placebo. In addition, in September, the company received its second patent for the treatment of Alzheimer’s disease; IGC-AD1 is partially based on this research. The report also noted that sales of the company’s CBD-infused products and services grew an estimated 345% for the six-month-period ended Sept. 30, 2022, compared to the same period from the previous year. “We are very pleased with the developments we have made this quarter, especially as they pertain to our investigational drug candidate, IGC-AD1,” said India Globalization Capital CEO Ram Mukunda in the press release. “We believe that we possess a revolutionary drug formulation that could provide much-needed relief for patients suffering from Alzheimer’s disease. This drug is the first natural low-dose THC (tetrahydrocannabinol)-based drug formulation to enter FDA trials and has the potential to fill a very prevalent void in the broad and expanding market for the treatment of Alzheimer’s symptoms.”

To view the full press release, visit https://ibn.fm/X130x

About India Globalization Capital Inc.

India Globalization Capital develops, patents and markets advanced THC-based drug formulations for the treatment of symptoms related to various diseases, including but not limited to Alzheimer’s disease, Parkinson’s disease, chronic pain and pet seizures. The company’s leading drug candidate, IGC-AD1, has demonstrated the potential to be effective in suppressing or ameliorating a key protein in Alzheimer’s cell lines responsible for Aβ plaques and has recently entered phase 2 clinical trials for agitation in dementia from Alzheimer’s. The company also has lines of various CBD-based consumer products such as Holief, which includes gummies and pain relief creams for women experiencing premenstrual syndrome (“PMS”) and dysmenorrhea (period cramps), and Sunday Seltzer, which includes a CBD-infused energy beverage — all currently available for purchase. The company also operates an Infrastructure business based in India. The company is headquartered in Maryland. For more information, visit the company’s website at www.IGCInc.us.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients with unmet medical need conditions, today announced that it will host a conference call and live webcast at 4:30 p.m. ET on Nov. 8, 2022, to discuss its third quarter 2022 results and provide an update on its clinical pipeline. Interested parties should visit https://ibn.fm/9cA3D to register for and access the live webcast and dial 888-506-0062 (toll-free) or 973-528-0011 (international) and enter code 178912 to join the call. Participants are asked to please log-on or dial-in approximately 5 to 10 minutes before the beginning of the call. Replay options are detailed in the press release for those unable to attend the live call and webcast.

To view the full press release, visit https://ibn.fm/ASDiQ

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include: PCS6422 (metastatic colorectal, breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (gastroparesis, functional constipation). The members of the Processa development team have been involved with more than 30 drug approvals by the FDA (including drug products targeted to orphan disease conditions) and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: N29), a metaverse company and leading provider of augmented reality (“AR”) experience technologies, wayfinding technologies and 3D model services, today announced that it and the company’s CEO Evan Gappelberg have acquired securities of Arway. According to the update, Gappelberg took ownership of 2,753,933 Arway common shares, while Nextech acquired 12.99 million Arway shares. Pursuant to the provisions of Section 288 of the Business Corporations Act, the shares were bought in connection with a plan of arrangement involving Nextech, Arway and 1373222 BC. As of Oct. 25, 2022, Nextech acquired 15.99 million shares representing approximately 60% of all issued and outstanding Arway shares. Following the recent transaction, the firm immediately transferred 3 million of such Arway shares to third parties. Gappelberg acquired 2,753,933 shares representing approximately 10.3% of all issued and outstanding Arway shares as of Oct. 25, 2022. Immediately prior to the acquisition, Gappelberg held no Arway shares.

To view the full press release, visit https://ibn.fm/lRrYU

About Nextech AR Solutions Corp.

Nextech is the engine accelerating the growth of the metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events, and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has started a takeoff roll toward blue skies that offer the potential promise of corporate development through public investment. “It announced in July that it is taking reservations from potential investors as it awaits qualification by the U.S. Securities and Exchange Commission (‘SEC’) for a public stock listing. This news was met by immediate enthusiasm from the investment community as evidence of the expectations of the backcountry aircraft market’s continued growth,” a recent article reads. In a recent interview with The Bell2Bell Podcast, CubCrafters Vice President of Sales and Marketing Brad Damm noted that despite COVID and European war-related challenges that have made it difficult for many companies to get needed products and deliver them to customers, CubCrafters has been able to continue operating smoothly. “Our biggest challenge in 2022 has been supply chain issues. We’ve been really fortunate that we’ve been able to overcome them,” Damm said in the interview. “We’ve actually managed to accelerate our manufacturing during this time period of supply chain challenges because the customer demand has been there.”

To view the full article, visit https://ibn.fm/MJMFt

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

NO MONEY OR OTHER CONSIDERATION IS BEING SOLICITED, AND IF SENT IN RESPONSE, WILL NOT BE ACCEPTED. NO OFFER TO BUY THE SECURITIES CAN BE ACCEPTED AND NO PART OF THE PURCHASE PRICE CAN BE RECEIVED UNTIL AN OFFERING STATEMENT FILED BY THE COMPANY WITH THE SEC HAS BEEN QUALIFIED BY THE SEC. ANY SUCH OFFER MAY BE WITHDRAWN OR REVOKED, WITHOUT OBLIGATION OR COMMITMENT OF ANY KIND, AT ANY TIME BEFORE NOTICE OF ACCEPTANCE GIVEN AFTER THE DATE OF QUALIFICATION.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Brain Scientific (OTCQB: BRSF), a Florida-based medical device technology company, today announced that Daniel Cloutier will serve as its chief revenue officer (“CRO”) in a move designed to propel the company forward on its mission to revolutionize the medical industry. Cloutier brings extensive knowledge and experience in sales strategy and global distribution. His successful track record includes founding LOK Corporation in 2011 after representing CAS Medical System (“CASMED”) as international sales director for eight years and launching the FORE-SIGHT cerebral oximetry internationally. “Daniel’s decades of leadership are crucial at this juncture for Brain Scientific to continue accelerating its path to revenue,” said Hassan Kotob, chairman and CEO of Brain Scientific. “With a growing number of opportunities and partners, Brain Scientific is poised for rapid growth in the immediate future.”

To view the full press release, visit https://ibn.fm/4Qhyp

About Brain Scientific Inc.

Brain Scientific is a medical technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of neurodiagnostic and OEM medical devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of medical devices. To learn more about Brain Scientific’s corporate strategy, products or investor relations, please visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Amesite (NASDAQ: AMST) is an artificial intelligence (“AI”)-powered software company providing cloud-based learning and content creation ecosystems for educational institutions, businesses and organizations. The company recently launched Version 5 (“V5”) of its AI-driven online learning platform, with the upgraded version built for scalability to deliver to large user bases with features that lead the industry. V5 also offers the capability to seamlessly integrate the platform with other software programs and partner sites. Amesite is leveraging a number of collaborations, and its partnership with Wayne State University’s College of Engineering is proof that Amesite is building systems that retain customers and enable them to scale. Amesite also highlighted the platform’s capabilities and recently reported on the successful delivery of a “Full Scale, Global Enterprise Learning Solution” for the EWIE Group of Companies (“EGC”). “We know that people are our most important resource. Having people with the most advanced skills is a huge competitive advantage for us,” said Jay Mullick, President of EGC. “Amesite is at the center of all our business process training at EGC. We have appreciated the support of their team throughout the relationship. Using Amesite’s global upskilling technology platform enables our people to gain the know-how to meet our most demanding customers’ needs, quickly and efficiently.”

To view the full press release, visit https://ibn.fm/gEk3r

About Amesite Inc.

Amesite, an artificial intelligence-driven platform and course designer, provides online products in the United States. The company uses machine learning to offer a mass customized experience to learners. Its customers include businesses, universities and colleges, K-12 schools, and non-profit organizations. The company was incorporated in 2017 and is headquartered in Detroit, Michigan. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DSG Global (OTCQB: DSGT) Chairman Bob Silzer today announced the appointment of Alan M. Wagner as chief executive officer of the company’s wholly owned subsidiary, Liteborne Motor Corporation(TM) (“LMC”), the newly reorganized and rebranded Imperium Motor Company. Wagner brings extensive expertise and reach across the automotive industry that will enable him to work closely with China-based Skywell Automotive Group with which LMC has exclusive rights to distribute its electric vehicles in North America. “I can’t think of anyone better than Alan to steward Liteborne through the homologation process and build a robust dealer network,” Silzer said in the news release. “His history working with every type of automotive industry professional is second-to-none. In addition, we are pleased to announce we will soon welcome several of his colleagues to LMC ‘s newly created board of directors.”

To view the full press release, visit https://ibn.fm/iaFMS

About DSG Global Inc.

DSG Global is publicly traded under the symbol DSGT. DSG Global’s leadership team consists of pioneers in fleet management systems for the golf industry, having launched one the original GPS and Wi-Fi-enabled platforms over 25 years ago, GPS Industries, which would eventually be purchased by Club Car. The company released its own proprietary fleet management system under the Vantage TAG brand. The Vantage TAG system is modular, so the operator has the flexibility to build a completely customized solution depending on the requirements of the operation. The system can be implemented with or without a range of displays from the efficient TEXT to the high-definition INFINITY. For utility vehicles there is the TAG TURF. Explore all the functionality of the Vantage TAG Fleet Management System and additional information at www.Vantage-TAG.com.

NOTE TO INVESTORS: The latest news and updates relating to DSGT are available in the company’s newsroom at https://ibn.fm/DSGT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Eat Well Investment Group (CSE: EWG) (OTC: EWGFF) (FRA: 6BC0), a publicly traded investment company, has announced its third quarter 2022 financial results, including record gross profit, and EBITDA of its wholly owned portfolio company Belle Pulses Ltd., plus record distribution and topline gains in CPG investments driven by Amara Infant Nutrition. “Our investee management teams are demonstrating very strong agility in protecting and enhancing margins and the underpinning long-term drivers of their respective businesses while they drive their scale,” said Marc Aneed, the company’s president and CEO. “With profitable, sustainable growth as their ‘true north,’ 2023 will be another record year for these investees and EWG continues to support them in addressing food security globally at this critical time in the world. We are confident that operational and financial foundations built out in 2022 will serve Eat Well and its investees well into the future.”

To view the full press release, visit https://ibn.fm/8AQLL

About Eat Well Investment Group Inc.

Eat Well Group is a publicly traded investment company primarily focused on high-growth companies in the agribusiness, food tech, plant-based and environmental, social and governance (“ESG”) sectors. Eat Well Group’s management team has an extensive record of sourcing, financing and building successful companies across a broad range of industries and maintains a current investment mandate on the health/wellness industry. The team has financed and invested in early stage venture companies for greater than 25 years, resulting in unparalleled access to deal flow and the ability to construct a portfolio of opportunistic investments intended to generate superior risk-adjusted returns. For more information about the company, visit www.EatWellGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to EWGFF are available in the company’s newsroom at https://ibn.fm/EWGFF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing products to improve survival and/or the quality of life for patients who have an unmet medical need conditions, is reporting positive results from its ongoing Next-Generation Capecitabine (“NGC”) phase 1B trial. According to the company, the trial indicates that NGC dosage regimens may have potential better safety and efficacy profiles than current chemotherapy options. The company is reporting that the NGC dosage regimens are significantly more potent than existing FDA-approved capecitabine therapy; they also form less of the metabolites that cause dose-limiting side effects with no tumor-killing properties. According to the announcement, the company anticipates meeting with the U.S. Food and Drug Administration (“FDA”) next year to confirm that its phase 2B trial design conforms with the agency’s Project Optimus Oncology initiative; that initiative is focused on identifying optimal dosing regimens while moving away from maximum tolerated dosing approach. The company also announced that it expects to enroll patients into its phase 2B trial beginning next year. “We have identified NGC regimens that have potency significantly greater than existing therapy and no dose-limiting side effects, unlike existing capecitabine therapy where approximately 25–60% of the patients require dose modifications or discontinuation,” said Processa Pharmaceuticals president and CEO Dr. David Young in the press release. “In addition, we understand the effect of different NGC regimens on the timeline of DPD irreversible inhibition and a patient’s production of new DPD, allowing us to better define the relationship between various NGC dosage regimens, 5-FU exposure and the safety of NGC.”

To view the full press release, visit https://ibn.fm/2vDUG

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses its Regulatory Science Approach criteria when selecting drugs for development to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include PCS6422 (“PCS6422”), a metastatic colorectal cancer and breast cancer program;  PCS499 (“PCS499”), an ulcerative necrobiosis lipoidica program; and PCS12852 (“PCS12852”), a gastroparesis, functional constipation program. Members of the Processa development team have been involved with more than 30 drug approvals for indications in almost every division of the FDA, including drug products targeted to orphan disease conditions, and more than 100 FDA meetings throughout their careers. For more information, visit the company’s website at www.ProcessaPharma.com. 

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Hero Technologies (OTC: HENC) CEO Gina Serkasevich has released statement about the future of the cannabis market, including the demand for legal marijuana. Hero Technologies is a cannabis company focused on a seed-to-sale vertical integration strategy. In her discussion, Serkasevich talks about the impact that inflation and recession might have on the U.S. cannabis market. In her statement, Serkasevich pointed to the economic downturn caused by the global pandemic, during which the cannabis industry experienced explosive growth while other industries struggled. According to the announcement, sales of legal cannabis in Michigan during 2021 soared 82% to $1.8 billion while many states expanded legalization of the substance. “We see evidence that the cannabis market can survive, or even thrive, in hard times,” said Hero Technologies CEO Gina Serkasevich in the press release. “The main factors driving growth in the U.S. cannabis market seem relatively impervious to recession. First, vast new markets are opening up — 34 states have now legalized some form of cannabis. Second, medical marijuana seems to have the same inelastic demand and price stability as other medicines; people don’t cut back on prescriptions no matter what is happening in the economy. Third, the use of recreational marijuana seems to mirror the use of alcohol in tough times. These substances serve as an escape or reward in the face of hardship. . . . Not only do we have sound reasons to expect that the U.S. cannabis market will do well even if the country falls into recession, market data suggests that the future for cannabis in America is very bright.”

To view the full press release, visit https://ibn.fm/NVyjJ

About Hero Technologies Inc.

Hero Technologies is a cannabis company working toward a vertically integrated business model. The company owns a majority stake in BlackBox Systems and Technologies LLC, an aeroponic cannabis cultivation system that provides optimal growing conditions to enhance photosynthesis and cultivation of large flowering plants, creating increased harvest efficiencies. The company’s strategic business plan includes cannabis genetic engineering, farmland for both medical and recreational cannabis cultivation, production licenses, distribution licenses, consumer packaging, and retail and dispensary operations that make the company a multistate operator (“MSO”). For more information about the company, please visit www.HeroTechnologiesInc.com.

NOTE TO INVESTORS: The latest news and updates relating to HENC are available in the company’s newsroom at https://ibn.fm/HENC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: N29), a metaverse company and leading provider of augmented reality (“AR”) experience technologies, wayfinding technologies and 3D model services, today announced plans to release its third quarter 2022 financial results after markets close on Thursday, Nov. 17, 2022. On that same day at 5 p.m. Eastern Time, Nextech will host a conference call to discuss the results. Nextech’s Chief Executive Officer Evan Gappelberg and Chief Financial Officer Andrew Chan will lead the discussion followed by a question-and-answer period. Interested parties should visit https://ibn.fm/xLdqN to register and may join the call by dialing 1 (888) 330-2024 (toll-free) or 1 (646) 960-0187 (international) and entering conference ID: 7778367. For those unable to join the live event, a recording of the presentation will be published on the company’s IR website.

To view the full press release, visit https://ibn.fm/Bsw5w

About Nextech AR Solutions Corp.

Nextech is the engine accelerating the growth of the metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events, and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at https://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), an innovative precommercial lithium company, has received notification from the U.S. Patent and Trademark Office (“USPTO”) regarding two patent applications. The company announced that the USPTO had issued Notices of Allowance for the applications, which both involved a novel and proprietary technique process for recovering Direct Lithium Extraction (“DLE”) from brine. According to the announcement, the USPTO issues a Notice of Allowance after it has examined a patent application and determined that a patent should be granted; the formal registration of the patents should occur in the coming months. SLI has one additional patent still pending, which also covers its DLE processes. “The successful Notice of Allowance from the USPTO provides continued affirmation of the company’s lithium extraction technology and allows Standard Lithium to continue advancing its first commercial lithium extraction project with even greater certainty of intellectual property rights,” said Standard Lithium president Dr. Andy Robinson in the press release.

To view the full press release, visit https://ibn.fm/xAxnE

About Standard Lithium Ltd.

Standard Lithium is an innovative lithium company moving rapidly towards commercialization. The company’s flagship project is located in southern Arkansas, where it is engaged in the design of its first commercial lithium project, intended to be constructed on 150,000 acres of existing permitted brine operations. The company operates its first-of-a-kind, industrial-scale Direct Lithium Extraction (“DLE”) demonstration plant at Lanxess’s south plant facility in southern Arkansas. The demonstration plant utilizes the company’s DLE technology to selectively extract lithium from Lanxess’s tail brine. The demonstration plant is being used for definitive feasibility and commercial engineering design studies. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. SLI is also pursuing the development of more than 30,000 acres of separate brine leases located in southwest Arkansas, referred to as the South West Arkansas Lithium Project, and approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. For more information about the company, please visit www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• An overwhelming majority of surveyed entrepreneurs (74.8%) reported being somewhat or very happy
• Guidant Financial report describes entrepreneurs as “backbone of the COVID recovery”
• SHRG and its Happy Company have been part of that wave of entrepreneurial growth

Small business owners tend to be happier, according to a recent Guidant Financial 2022 trends report (https://ibn.fm/jrhWW). The report just reaffirms what Sharing Services Global (OTCQB: SHRG) already knew when it rebranded its direct-sales division as The Happy Company early last year.

“Entrepreneurs are just happier, according to Guidant Financial’s 2022 Small Business Trends report,” states a Direct Selling News article. “The past two years and counting have been inordinately challenging for small business owners, but even amid these struggles, an overwhelming majority of these…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Global public sector leaders, professionals, and regulators, and representatives from the public, healthcare, emergency services, are invited to attend the Intelligent Cities Canada, IOT People First Summit. 

The Intelligent Cities Summit brings global leaders of the public sector on a common platform to discuss vital issues of citizen engagement and citizen experience. Thought leaders share insights to create an efficient public sector for the future. They discuss and derive suitable solutions that utilize…

Read More>>

To learn more, please visit https://ibn.fm/P3T1t

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Sustainable Green Team (OTC: SGTM), an emerging provider of environmentally beneficial solutions for preserving natural resources and the municipal waste and recycling industries, will be featured in an upcoming episode of “New to the Street,” a nationally syndicated program. The company is one of five to be featured on New to the Street’s 402nd broadcast, airing at 10:30 p.m. PT on Monday, Oct. 31, 2022, on the Fox Business Network. The Ecology Solutions segment will air the corporate documentary on the business relationship between the Sustainable Green Team and Australian company VRM BioLogik Group. Kellie Walters, CEO of the VRM BioLogik Group, explains the company’s mission in restoring topsoil’s water content and nutrition for 25% of the globe’s arable lands. The VRM BioLogik Group’s founder/president dedicated over 30 years to developing and deploying the HumiSoil product to improve all soil types and increase worldwide agricultural yields. In 2020, the Sustainable Green Team’s Tony Raynor, and his wife, Tami Raynor, entered into a collaboration with VRM BioLogik. Under the partnership, SGTM will utilize VRM BioLogik Group’s hydrosynthesis technology in the U.S. to create the HumiSoil product for sale and distribution in the North American marketplace. With the Earth’s population of about eight billion, farmable land is becoming scarce. As both entities work in tandem, they can expand agricultural reach of the revolutionary HumiSoil. The documentary highlights views on the ecological visions of both entities and shows practical solutions now available.

To view the full press release, visit https://ibn.fm/T77wT

About Sustainable Green Team Ltd.

The Sustainable Green Team is an emerging provider of environmentally beneficial solutions for preserving natural resources and the municipal waste and recycling industries. The company is a wholesale manufacturer and supplier of wood-based mulch and lumber products, primarily in the Midwest, Southeast and Ohio Valley regions. The company also provides arbor care and storm recovery services to municipalities, corporations and consumers, primarily in the southeastern United States. The company plans to expand its operations through organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential and commercial clients. For more information about the company, visit – www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.